Skip to main content
. Author manuscript; available in PMC: 2013 Aug 22.
Published in final edited form as: Mem Inst Oswaldo Cruz. 2012 Sep;107(6):760–766. doi: 10.1590/s0074-02762012000600009

TABLE I.

Characteristics of patients with pulmonary tuberculosis (TB) who met the criteria for tuberculosis drug susceptibility testing (DST), Santos, Brazil, 2000–2004

Underwent DST
Yes (n = 213) No (n = 458) Total (n = 671)
Characteristics n (%) n (%) n (%) p
Gender 0.23
 Female 57 (27.4) 143 (31.2) 200 (29.8) -
 Male 156 (73.2) 315 (68.8) 471 (70.2) -
Age (years)
 15–19 4 (1.9) 10 (2.2) 14 (2.1) 0.76
 20–49 167 (78.4) 368 (80.3) 535 (79.7) -
 50 or more 42 (19.7) 80 (17.5) 122 (18.2) -
Schooling 0.28
 Up to 7 years 61 (34.7) 162 (44.6) 223 (41.4) -
 8 years or more 115 (65.3) 201 (55.4) 316 (58.6) -
Alcohol dependence 0.14
 No 166 (83) 379 (87.7) 545 (86.2) -
 Yes 34 (17) 53 (12.3) 87 (13.8) -
HIV infection < 0.0003
 No 127 (60.8) 194 (43.7) 321(49.2) -
 Yes 82 (39.2) 250 (56.3) 332 (50.8) -
Past history of TB 0.25
 No 86 (40.4) 161 (37.1) 247 (38.2) -
 Yes 127 (59.6) 273 (62.9) 400 (61.8) -
Outcome of prior TB treatment 0.57
 Cure 45 (35. 7) 114 (41.8) 159 (39.8) -
 Dropout 81 (64. 3) 159 (58.2) 240 (60.2) -
Relapse 0.27
 No 169 (82) 300 (76.0) 499 (78) -
 Yes 37 (18) 104 (24.0) 141 (22) -
Cavitary pulmonary lesions < 0.0001
 No 128 (68.1) 331 (84.9) 459 (79.4) -
 Yes 60 (31.9) 59 (15.1) 119 (20.6) -
Treatment regimen < 0.0001
 Unchanged 173 (87.8) 422 (96.6) 595 (93.8) -
 Changed 24 (12.2) 15 (3.4) 39 (6.2) -
Treatment completion
 Cure 127(67.2) 255 (62.3) 382 (63.9) 0.24
 Unfavourable outcomea 63 (32.8) 154 (37.7) 217 (36.1) -
a

dropout, deaths from TB and acquired immune deficiency syndrome, treatment failure;

HIV: human immunodeficiency virus.

Inconsistencies between total patients studied and total variables are due to missing information.